Now a new study from Boston University School of Medicine (BUSM) highlights the impact that structural racism and residential segregation has on NSCLC outcomes.
News | Lung Imaging
Racism and Segregation Associated with Advanced Stage Lung Cancers Among Blacks

June 29, 2021 — Lung cancer remains the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) ...

Time June 29, 2021
Home
The RefleXion X1 is the world’s first biology-guided radiotherapy (BgRT) machine that’s expected to improve treatment and expand options for patients with metastatic disease, where few treatments are currently available.
News | Radiation Therapy
UPMC Hillman Cancer Center Among First in Country to Offer Radiotherapy That Lets Tumors Guide Treatment

June 29, 2021 — UPMC Hillman Cancer Center will be the first cancer center in the eastern United States, and one of just ...

Time June 29, 2021
Home
The U.S. Food and Drug Administration (FDA) approved a new imaging agent for detection of prostate cancer, providing a more effective imaging approach to detect the spread of cancer to other parts of the body. Piflufolastat F-18 injection is the first fluorinated prostate-specific membrane antigen (PSMA) agent approved by the FDA and also the first commercially available PSMA PET imaging agent.
News | PET Imaging
FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer

June 28, 2021 — The U.S. Food and Drug Administration (FDA) approved a new imaging agent for detection of prostate ...

Time June 28, 2021
Home
RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier universitaire vaudois (CHUV) in Lausanne, Switzerland, which will include orders for RayStation RayCare and RayIntelligence. 
News | Oncology Information Management Systems (OIMS)
Raysearch Signs Agreements with Switzerland Clinics

June 28, 2021 — RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier ...

Time June 28, 2021
Home
Siemens Healthineers and Prisma Health announced today a 10-year strategic relationship to help create a better state of health for South Carolina.
News | Radiology Business
Siemens Healthineers and Prisma Health Join Forces to Innovate Healthcare for South Carolina

June 28, 2021 — Siemens Healthineers and Prisma Health announced today a 10-year strategic relationship to help create a ...

Time June 28, 2021
Home
Screen Shot 2021-06-25 at 1.01.45 PM
Sponsored Content | Blog | Enterprise Imaging
BLOG: Orchestrating Radiology Workflow in a Large, Distributed Reading Environment

Large radiology groups often face challenges distributing workflow effectively and fairly across the organization ...

Time November 05, 2021
Home
Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding nonmelanoma skin cancer. Additionally, the National Cancer Institute recently predicted an almost 10,000 excess deaths from breast and colorectal cancers over the next 10 years as a direct result of the pandemic, making it now more important than ever for women to take control over their breast health.
News | Artificial Intelligence
How AI is Helping the Fight Against Breast Cancer

June 25, 2021 — Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding ...

Time June 25, 2021
Home
Alliance HealthCare Services, Inc., a leading national provider of radiology and oncology solutions to hospitals, health systems and physician groups, announced today that it has entered into an agreement to be acquired for $820 million by Akumin Inc., a premier provider of freestanding outpatient radiology services in the U.S.
News | Radiology Business
Alliance Healthcare Services Announces Acquisition by and Integration with Akumin

June 25, 2021 — Alliance HealthCare Services, Inc., a leading national provider of radiology and oncology solutions to ...

Time June 25, 2021
Home
Patients with primary lung cancer detected using low-dose computed tomography screening are at reduced risk of developing brain metastases after diagnosis, according to a study published in the Journal of Thoracic Oncology.
News | Computed Tomography (CT)
Primary Lung Cancers Detected by LDCT are at Lower Risk of Brain Metastases

June 25, 2021 — Patients with primary lung cancer detected using low-dose computed tomography screening are at reduced ...

Time June 25, 2021
Home
The two-year project focused on reducing the use of extended-fraction radiation therapy to treat pain from incurable cancer that had spread to patients’ bones. Once a standard practice, the American Society for Radiation Oncology (ASTRO) has recommended against the routine use of extended-fraction radiation to relieve pain from bone metastases, especially more than 10 treatments.
News | Radiation Therapy
Statewide Quality Improvement Project Reduced Excessive Radiation Treatments for Bone Metastases by 80%

June 24, 2021 — An effort by the Michigan Radiation Oncology Quality Consortium reduced excessive radiation treatments ...

Time June 24, 2021
Home
COVID-19 progression over 4 days in a 28-year-old man. This posteroranterior chest X-ray \ shows bilateral multiple peripheral and lower lobe ground glass opacities (GGOs) shown by the arrows. Image courtesy of Margarita Revzin et al. 
News | Artificial Intelligence
Medical AI Models Rely on 'Shortcuts' That Could Lead to Misdiagnosis of COVID-19

June 24, 2021 — Artificial intelligence promises to be a powerful tool for improving the speed and accuracy of medical ...

Time June 24, 2021
Home
 Mevion Medical Systems announced that the first proton center in the Mountain West, the Senator Orrin G. Hatch Center for Proton Therapy, has opened at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) and began treating patients on May 11 with the MEVION S250i Proton Therapy System.
News | Proton Therapy
Huntsman Cancer Institute Begins Treatment with Mevion Compact Proton Therapy System

June 24, 2021 — Mevion Medical Systems announced that the first proton center in the Mountain West, the Senator Orrin G ...

Time June 24, 2021
Home
Researchers have developed an artificial intelligence (AI)-based brain age prediction model to quantify deviations from a healthy brain-aging trajectory in patients with mild cognitive impairment, according to a study published in Radiology: Artificial Intelligence. The model has the potential to aid in early detection of cognitive impairment at an individual level.
News | Artificial Intelligence
Researchers Use AI to Track Cognitive Deviation in Aging Brains

June 23, 2021 — Researchers have developed an artificial intelligence (AI)-based brain age prediction model to quantify ...

Time June 23, 2021
Home
An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.
News | Coronavirus (COVID-19)
RSNA Announces Funding Program for MIDRC Data Contributors

June 23, 2021 — The Radiological Society of North America (RSNA) is inviting proposals from researchers for funding ...

Time June 23, 2021
Home
Led by a Michigan Medicine physician, the research team examined treatment outcomes over two years for patients who fractured their distal radius, the larger of two bones in the forearm. They found no one-size-fits all method for treating the fracture, which more than 85,000 Medicare beneficiaries sustain annually.
News | Radiology Imaging
Personalized Medicine, Not X-rays, Should Guide Fracture Treatments in Older Adults

June 23, 2021 — A decade-long study of the most common forearm fracture in older adults revealed that personalized ...

Time June 23, 2021
Home
According to a new study, by the Harvey L. Neiman Health Policy Institute and the American College of Radiology’s National Mammography Database Committee, the most influential radiologist characteristics impacting mammography interpretive performance were geography, breast sub-specialization, performance of diagnostic mammography, and performance of diagnostic ultrasound.
News | Breast Imaging
Study Finds Radiologist Characteristics Predict Performance in Screening Mammography

June 23, 2021 — According to a new study by the Harvey L. Neiman Health Policy Institute and the American College of ...

Time June 23, 2021
Home
New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines call for heightened screening attention for transgender individuals, Black women and other often overlooked or underserved populations.
News | Breast Imaging
New ACR/SBI Breast Cancer Screening Guidelines Address Heightened Risk for LGBTQ Persons and Black Women

June 22, 2021 — New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening ...

Time June 22, 2021
Home
GE Healthcare also recently announced Xeleris V, a new virtualized, flexible AI-powered solution that provides clinicians secure access to data from anywhere – helping them make personalized care decisions and treatment recommendations that are at the heart of precision health.
News | Nuclear Imaging
GE Healthcare Advances Precision Health & Theranostics With New Products & Solutions

June 22, 2021 — At the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2021 summer conference, GE Healthcare ...

Time June 22, 2021
Home
Master Supply Agreement encompasses clinical development and commercial supply for Clarity’s Cu-67-based candidates to treat neuroblastoma, breast and prostate cancers, among others
News | Radiopharmaceuticals and Tracers
NorthStar Medical Radioisotopes Enters U.S. Supply Agreement for Commercial Supply of Therapeutic Radioisotope Copper-67 (Cu-67)

June 22, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time June 22, 2021
Home
A phase III clinical trial has validated the effectiveness of the prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL in detecting and localizing recurrent prostate cancer.
News | Prostate Cancer
PSMA-Targeted Radiotracer Pinpoints Metastatic Prostate Cancer Across Anatomic Regions

June 21, 2021 — A phase III clinical trial has validated the effectiveness of the prostate-specific membrane antigen ...

Time June 21, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now